Engineered immune cells with micro-clusters
Grant
US12595291B2
Kind: B2
Apr 07, 2026
Assignee
A2 BIOTHERAPEUTICS, INC.
Inventors
Alexander Kamb
Abstract
The present disclosure provides engineered immune cells and methods for their creation and use. The immune cells comprise activating and blocking receptors, which form into micro-clusters upon contacting a target or non-target cell.
CPC Classifications
C12N 5/0637
A61K 35/17
Filing Date
2021-09-21
Application No.
17480487
Claims
16